Purchase Order 75N95023P00427

Award Date 7/14/23
Potential Completion Date 7/13/24
Potential Value $19K
Contracting Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
2323 Riverside Dr., Ottawa, ON K1H 1A1, Canada
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services' National Institutes of Health Clinical Center awarded a $12,000 purchase order to Science Suite Inc., doing business as Biorender, for science communication services. Under the firm fixed price contract, Biorender will provide its suite of science illustration and communication tools to support NIH's research programs over the course of one year. As a small business, Biorender may benefit from certain small business preferences in federal contracting....
This is a firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences, a component of the Department of Health and Human Services, to Science Suite Inc. (doing business as Biorender), a woman-owned small business. The $18,840 contract provides a 12-month license for Biorender's scientific illustration and communication software suite. This award supports the agency's research programs across areas like diabetes, kidney disease, cancer, and heart disease by...
The federal contract award is to Science Suite Inc., doing business as Biorender, a woman-owned small business that provides scientific illustration and communication software tools and services. The $16,155.00 firm fixed price purchase order from the National Institutes of Health (NIH) supports the delivery of Biorender's suite of visualization and collaboration software products, including licenses and subscription services, to the NIH Clinical Center. This contract does not have a set-aside...
The National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, awarded a $10,770.00 firm fixed price purchase order to Science Suite Inc., doing business as Biorender. This contract is for the provision of Biorender's scientific illustration and communication software tools and services, which support research programs across areas like diabetes, kidney disease, cancer, and heart disease. Science Suite Inc. has...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded an $87,771 fixed-price delivery order to Ideal System Solutions, Inc. for the renewal of BioRender software. Ideal System Solutions will perform under the Chief Information Officer Commodities and Solutions government-wide acquisition contract vehicle. Place of performance will be in Pequot Lakes, Minnesota. The period of performance is one year, from July 14,...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a component of the U.S. Department of Health and Human Services, awarded a $14,955.00 firm fixed price purchase order to Science Suite Inc., doing business as Biorender, for the renewal of Biorender's scientific illustration and visualization software licenses and services. This award supports NIDDK's research programs across areas like diabetes, kidney disease, cancer, and heart disease by providing NIH researchers...
This is a firm fixed-price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services (HHS), to New TECH Solutions, Inc., a minority-owned small business. The contract is for the renewal of BioRender software licenses, with a ceiling value of $86,250.83 and a period of performance through July 13, 2025. This order is placed under the Chief Information Officer Commodities and Solutions...
The National Heart, Lung and Blood Institute (NHLBI) awarded a $22,789.20 firm fixed price delivery order against the Solutions for Enterprise-Wide Procurement (SEWP V) government-wide acquisition contract (GWAC) vehicle. The purpose of this order is to purchase a 12-month unlimited license for BioRender Institutional from Govsmart, Inc. to continue providing NIH researchers with access to this scientific illustration software for creating drawings for publications and presentations. BioRender...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Delivery Order to Ideal System Solutions, Inc. for BioRender software licenses. The $27,615.32 firm fixed-price contract was placed under the Chief Information Officer Commodities and Solutions (CIO-CS) Government-Wide Acquisition Contract (GWAC), which is an Indefinite Delivery, Indefinite Quantity (IDIQ) multiple-award contract vehicle managed by the...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $18,840.00 firm fixed price purchase order to Science Suite Inc., doing business as Biorender, for a Biorender software license. The contract supports NIDDK's research programs across areas like diabetes, kidney disease, cancer, and heart disease by providing Biorender's suite of visualization and collaboration software products, including licenses and subscription services, to NIDDK researchers. As a Woman...

The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $18,840 firm fixed price purchase order to Science Suite Inc., doing business as Biorender, for a Biorender Software License (Science Suite). Under this contract, Biorender will provide its Science Suite of visualization and collaboration software tools to support NIH's research efforts. The place of performance is Biorender's headquarters in Ottawa, Canada. The period of performance is one year, from July 14, 2023 through July 13, 2024. No subcontractors or set aside designations were identified. This purchase augments NIH's research capabilities through specialized visualization software from Biorender.

Generated 12/20/23, 4:47 AM